alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
xml version="1.0" encoding="UTF-8"?


C\_2018297EN.01000601.xml


| | | | |
| --- | --- | --- | --- |
| 23.8.2018 | EN | Official Journal of the European Union | C 297/6 |

---

Prior notification of a concentration

(Case M.8956 — Biogen/Samsung BioLogics/Bioepis JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 297/07)

1.

On 17 August 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018297EN.01000601-E0001) by which Biogen Inc. (‘Biogen’, United States) and Samsung BioLogics Co. Ltd. (‘Samsung BioLogics’, South Korea), a company controlled by the Samsung Group (South Korea), acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of Samsung Bioepis Co Ltd. (‘Bioepis’, South Korea), currently solely controlled by Samsung BioLogics.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

—   for Biogen: a biopharmaceutical company active in research, development and provision of therapies for serious neurological and neurodegenerative diseases worldwide,

—   for Samsung BioLogics: a company active in the development and manufacturing of biopharmaceutical products worldwide,

—   for Samsung Group: a conglomerate active in a wide array of industries, including electronics, shipbuilding, engineering and insurance,

—   for Bioepis: active in the development of biosimilar medicines. Bioepis is a joint venture between Samsung BioLogics and Biogen.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2018297EN.01000601-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.8956 — Biogen/Samsung BioLogics/Bioepis JV

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018297EN.01000601-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2018297EN.01000601-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
Exhibit 31.2





CERTIFICATION OF CHIEF FINANCIAL OFFICER


Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002





I, Darren C. Dunckel, certify that:





(1) I have reviewed this quarterly report on Form 10-Q of Atomic Paintball Inc., (Registrant).





(2) Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;





(3) Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;





(4) The registrants other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:





(a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;





(b) evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and





(c) disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an quarterly report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and





(5) The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of the internal control over financial reporting, to the registrants auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):





(a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial information ; and





(b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal control over financial reporting.








Dated: July 1, 2014








By:
/s/ Darren C. DunckelDarren C. DunckelChief Financial Officer
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

IN RE: COPART, INC., COPART 

OF HOUSTON, INC., AND

HOUSTON COPART SALVAGE

AUTO AUCTIONS, LP.

 Relators.

§

§

§

§

§

§

§

No. 08-18-00034-CV

AN ORIGINAL PROCEEDING

IN MANDAMUS

O R D E R

The Court set the above-entitled and numbered cause for submission on October 18, 2018 

with oral argument. After reviewing the briefs and the record in the above-entitled and numbered 

cause, the Court has determined that oral argument is unnecessary. See TEX.R.APP.P. 39.1(d). The 

case will be submitted to the Court on October 18, 2018 without oral argument.

IT IS SO ORDERED this 8th day of October, 2018.

PER CURIAM

Before McClure, C.J., Rodriguez and Palafox, JJ.
I 

113TH CONGRESS 

1ST SESSION H. R. 1036 

To designate the facility of the United States Postal Service located at 

103 Center Street West in Eatonville, Washington, as the ‘‘National 

Park Ranger Margaret Anderson Post Office’’. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 7, 2013 

Mr. REICHERT (for himself, Ms. HERRERA BEUTLER, Ms. DELBENE, Mr. 

HASTINGS of Washington, Mr. HECK of Washington, Mr. KILMER, Mr. 

LARSEN of Washington, Mr. MCDERMOTT, Mrs. MCMORRIS RODGERS, 

and Mr. SMITH of Washington) introduced the following bill; which was 

referred to the Committee on Oversight and Government Reform 

A BILL 

To designate the facility of the United States Postal Service 

located at 103 Center Street West in Eatonville, Washington, as the ‘‘National Park Ranger Margaret Anderson Post Office’’. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. NATIONAL PARK RANGER MARGARET ANDER4 SON POST OFFICE. 

5 (a) DESIGNATION.—The facility of the United States 

6 Postal Service located at 103 Center Street West in 

7 Eatonville, Washington, shall be known and designated as 


smartinez on DSK6TPTVN1PROD with BILLS
2 

•HR 1036 IH

1 the ‘‘National Park Ranger Margaret Anderson Post Of2 fice’’. 

3 (b) REFERENCES.—Any reference in a law, map, reg4 ulation, document, paper, or other record of the United 

5 States to the facility referred to in subsection (a) shall 

6 be deemed to be a reference to the ‘‘National Park Ranger 

7 Margaret Anderson Post Office’’. 

Æ 


smartinez on DSK6TPTVN1PROD with BILLS
113TH CONGRESS 

1ST SESSION H. R. 1241 

AN ACT 

To facilitate a land exchange involving certain National Forest System lands in the Inyo National Forest, and for 

other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 
2 

•HR 1241 EH

1 SECTION 1. SPECIAL RULES FOR INYO NATIONAL FOREST 

2 LAND EXCHANGE. 

3 (a) AUTHORITY TO ACCEPT LANDS OUTSIDE

4 BOUNDARIES OF INYO NATIONAL FOREST.—In any land 

5 exchange involving the conveyance of certain National 

6 Forest System land located within the boundaries of Inyo 

7 National Forest in California, as shown on the map titled 

8 ‘‘Federal Parcel’’ and dated June 2011, the Secretary of 

9 Agriculture may accept for acquisition in the exchange 

10 certain non-Federal lands in California lying outside the 

11 boundaries of Inyo National Forest, as shown on the maps 

12 titled ‘‘DWP Parcel – Interagency Visitor Center Parcel’’ 

13 and ‘‘DWP Parcel – Town of Bishop Parcel’’ and dated 

14 June 2011, if the Secretary determines that acquisition 

15 of the non-Federal lands is desirable for National Forest 

16 System purposes. 

17 (b) CASH EQUALIZATION PAYMENT; USE.—In an ex18 change described in subsection (a), the Secretary of Agri19 culture may accept a cash equalization payment in excess 

20 of 25 percent. Any such cash equalization payment shall 

21 be deposited into the account in the Treasury of the 

22 United States established by Public Law 90–171 (com23 monly known as the Sisk Act; 16 U.S.C. 484a) and shall 

24 be made available to the Secretary for the acquisition of 

25 land for addition to the National Forest System. 
3 

•HR 1241 EH

1 (c) RULE OF CONSTRUCTION.—Nothing in this sec2 tion shall be construed to grant the Secretary of Agri3 culture new land exchange authority. This section modifies 

4 the use of land exchange authorities already available to 

5 the Secretary as of the date of the enactment of this Act. 

Passed the House of Representatives December 3, 

2013. 

Attest: 

Clerk. 
113TH CONGRESS 

1ST SESSION H. R. 1241 

AN ACT 

To facilitate a land exchange involving certain NaForest, and for other purposes. tional Forest System lands in the Inyo National
Randy Dale JACKSON, Petitioner, v. Tommy TAYLOR, Interim Commissioner, Mississippi Department of Corrections.

No. 19-8086.

Supreme Court of the United States.

May 26, 2020

Petition for writ of certiorari to the United States Court of Appeals for the Fifth Circuit denied.
```
 
 
MSCI EAFE MINI INDEX - NYSE LIFFE                                    Code-244041
FUTURES ONLY POSITIONS AS OF 03/04/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:      107,204
COMMITMENTS
  23,651    9,834    5,759   71,433   88,496  100,843  104,089    6,361    3,115

CHANGES FROM 02/25/14 (CHANGE IN OPEN INTEREST:        134)
    -429      -86      -47    1,061      193      585       60     -451       74

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    22.1      9.2      5.4     66.6     82.5     94.1     97.1      5.9      2.9

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:       93)
      14        7        3       53       37       68       46
 
 
MSCI EMERGING MKTS MINI INDEX - NYSE LIFFE                           Code-244042
FUTURES ONLY POSITIONS AS OF 03/04/14                         |
--------------------------------------------------------------| NONREPORTABLE
      NON-COMMERCIAL      |   COMMERCIAL    |      TOTAL      |   POSITIONS
--------------------------|-----------------|-----------------|-----------------
  LONG  | SHORT  |SPREADS |  LONG  | SHORT  |  LONG  | SHORT  |  LONG  | SHORT
--------------------------------------------------------------------------------
(MSCI EAFE INDEX X $50)                              OPEN INTEREST:      258,503
COMMITMENTS
  79,208   36,721    6,933  160,110  204,881  246,251  248,535   12,252    9,968

CHANGES FROM 02/25/14 (CHANGE IN OPEN INTEREST:      4,347)
  -5,959      108    3,410    6,176    1,680    3,627    5,198      720     -851

PERCENT OF OPEN INTEREST FOR EACH CATEGORY OF TRADERS
    30.6     14.2      2.7     61.9     79.3     95.3     96.1      4.7      3.9

NUMBER OF TRADERS IN EACH CATEGORY (TOTAL TRADERS:      189)
      57       28       10       75       62      137       95
```

----

Updated March 7, 2014
Order issued October 29, 2013 Withdrawn; Order filed November 26, 2013. 

In The

Fourteenth Court of Appeals

____________

NO. 14-13-00568-CV

____________

LIZZIE J. LOVALL, INDIVIDUALLY; KEITH L. SHAW; 

INDIVIDUALLY: KENNETH L. YOUNG; INDIVIDUALLY; KIM L. 

SHAW, INDIVIDUALLY, Appellants

V.

HARRIS COUNTY, TEXAS, INDIVIDUALLY, OFFICIALLY AND 

VICARIOUSLY; MAY WALKER, CONSTABLE, PRECINCT 7, 

INDIVIDUALLY; RUTH MCDUGLE, INDIVIDUALLY; DARLA 

TURNER, INDIVIDUALLY; JOHN K. GEORGE, OFFICIALLY, 

INDIVIDUALLY; GOW-MING CHAO, INDIVIDUALLY; ET AL, 

Appellees

On Appeal from the 190th District Court

Harris County, Texas

Trial Court Cause No. 2011-23410

ORDER

On November 13, 2013, appellees filed a motion to reconsider the court’s 

order finding appellants indigent. Appellees motion is granted. This court’s order 
of October 29, 2013 is withdrawn. Appellants filed a document on October 7, 

2013 that this court is liberally construing as an affidavit of indigence filed in this 

court. See Tex. R. App. P. 20.1(d)(2). Pursuant to Tex. R. App. P. 20.1(d)(2), a 

copy of the document is attached to this order and is sent to the court reporter for 

the 190th District Court and the Harris County District Clerk. A contest to 

appellants’ affidavit of indigence is due in this court on or before December 6, 

2013.

PER CURIAM
xml version="1.0" encoding="UTF-8"?


C\_2018313EN.01000201.xml


| | | | |
| --- | --- | --- | --- |
| 5.9.2018 | EN | Official Journal of the European Union | C 313/2 |

---

Prior notification of a concentration

(Case M.9098 — Goldman Sachs/Orix/ILS)

Candidate case for simplified procedure

(Text with EEA relevance)

(2018/C 313/02)

1.

On 29 Augustus 2018, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 [(1)](#ntr1-C_2018313EN.01000201-E0001).

This notification concerns the following undertakings:

| | |
| --- | --- |
| — | Goldman Sachs (United States), |

| | |
| --- | --- |
| — | ORIX Kabushiki Kaisha (‘Orix Corporation’) (Japan), |

| | |
| --- | --- |
| — | ILS (Japan). |

Goldman Sachs and Orix Corporation acquire within the meaning of Article 3(1)(b) of the Merger Regulation joint control of the whole of ILS.

The concentration is accomplished by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

| | |
| --- | --- |
| — | Goldman Sachs is a global investment banking, securities and investment management firm incorporated in the United States. |

| | |
| --- | --- |
| — | Orix Corporation is a multinational integrated financial services and investment group headquartered in Japan. |

| | |
| --- | --- |
| — | ILS is a pharmaceutical company incorporated in Japan. |

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 [(2)](#ntr2-C_2018313EN.01000201-E0002) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified:

M.9098 — Goldman Sachs/Orix/ILS

Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below:

| |
| --- |
| Email: COMP-MERGER-REGISTRY@ec.europa.eu |
| Fax +32 22964301 |
| Postal address: |
| European Commission |
| Directorate-General for Competition |
| Merger Registry |
| 1049 Bruxelles/Brussel |
| BELGIQUE/BELGIË |

---

[(1)](#ntc1-C_2018313EN.01000201-E0001)  [OJ L 24, 29.1.2004, p. 1](http://publications.europa.eu/resource/oj/JOL_2004_024_R_TOC) (the ‘Merger Regulation’).

[(2)](#ntc2-C_2018313EN.01000201-E0002)  [OJ C 366, 14.12.2013, p. 5](http://publications.europa.eu/resource/oj/JOC_2013_366_R_TOC).

---
Davon Kelly BENNETT, Petitioner, v. UNITED STATES.

No. 18-9446

Supreme Court of the United States.

October 7, 2019

Petition for writ of certiorari to the United States Court of Appeals for the Fourth Circuit denied.
# C_2020363EN.01025701.xml

| 28.10.2020 | EN | Official Journal of the European Union | C 363/257 |
| --- | --- | --- | --- |

28.10.2020

EN

Official Journal of the European Union

C 363/257

---

P8_TA(2018)0450

State aid rules: new categories of State aid *

European Parliament legislative resolution of 14 November 2018 on the proposal for a Council regulation amending Council Regulation (EU) 2015/1588 of 13 July 2015 on the application of Articles 107 and 108 of the Treaty on the Functioning of the European Union to certain categories of horizontal State aid (COM(2018)0398 — C8-0316/2018 — 2018/0222(NLE))

(Consultation)

(2020/C 363/31)

The European Parliament,

| — | having regard to the Commission proposal to the Council (COM(2018)0398), |
| --- | --- |

—

having regard to the Commission proposal to the Council (COM(2018)0398),

| — | having regard to Article 109 of the Treaty on the Functioning of the European Union, pursuant to which the Council consulted Parliament (C8-0316/2018), |
| --- | --- |

—

having regard to Article 109 of the Treaty on the Functioning of the European Union, pursuant to which the Council consulted Parliament (C8-0316/2018),

| — | having regard to Rule 78c of its Rules of Procedure, |
| --- | --- |

—

having regard to Rule 78c of its Rules of Procedure,

| — | having regard to the report of the Committee on Economic and Monetary Affairs (A8-0315/2018), |
| --- | --- |

—

having regard to the report of the Committee on Economic and Monetary Affairs (A8-0315/2018),

| 1. | Approves the Commission proposal; |
| --- | --- |

1.

| 2. | Calls on the Council to notify Parliament if it intends to depart from the text approved by Parliament; |
| --- | --- |

2.

| 3. | Asks the Council to consult Parliament again if it intends to substantially amend the text approved by Parliament; |
| --- | --- |

3.

| 4. | Instructs its President to forward its position to the Council and the Commission. |
| --- | --- |

4.

---
**Exhibit 32.2**




**CERTIFICATION
      PURSUANT TO**


**18
      U.S.C. SECTION 1350,**


**AS
      ADOPTED PURSUANT TO**


**SECTION 906
      OF THE SARBANES-OXLEY ACT OF 2002**




In
      connection with the Quarterly Report of Physicians Formula Holdings, Inc.
      (the “Company”) on Form 10-Q for the quarter ended June 30, 2007, as filed
      with the Securities and Exchange Commission (the “Report”), I, Joseph J. Jaeger,
      Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as
      adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:




(1)The
                Report fully complies with the requirements of Section 13(a) or
                15(d) of the Securities Exchange Act of 1934;
                and




(2)The
                information contained in the Report fairly presents, in all material
                respects, the financial condition and results of operations of the
                Company.




The
      foregoing certification is being furnished solely pursuant to 18 U.S.C. §1350
      and is not being filed as part of the Report or as a separate disclosure
      document.




Date:
      August 13, 2007




By:
            /s/
                Joseph J. JaegerName:
            Joseph
                J. JaegerTitle:
            Chief
                Financial Officer







A
      signed
      original of this written statement required by Section 906, or other
      document authenticating, acknowledging, or otherwise adopting the signature
      that
      appears in typed form within the electronic version of this written statement
      required by Section 906, has been provided to Physicians Formula
      Holdings, Inc. and will be retained by Physicians Formula
      Holdings, Inc. and furnished to the Securities and Exchange Commission or
      its staff upon request.
[Federal Register Volume 87, Number 117 (Friday, June 17, 2022)]
[Notices]
[Pages 36454-36455]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-13201]


=======================================================================
-----------------------------------------------------------------------

COMMISSION ON CIVIL RIGHTS


Sunshine Act Meeting

AGENCY: United States Commission on Civil Rights.

ACTION: Notice of Commission public business meeting.

-----------------------------------------------------------------------

DATES: Friday, June 24, 2022, 12:00 p.m. EST.

ADDRESSES: Meeting to take place by telephone and is open to the public 
by telephone: 877-222-5769 ID Code #: 1911248.

FOR FURTHER INFORMATION CONTACT: Angelia Rorison: 202-376-8371; 
<a href="/cdn-cgi/l/email-protection#403035222c2923212626212932330035332323326e272f36"><span class="__cf_email__" data-cfemail="512124333d3832303737303823221124223232237f363e27">[email protected]</span></a>.

SUPPLEMENTARY INFORMATION: In accordance with the Government in 
Sunshine Act (5 U.S.C. 552b), the Commission on Civil Rights is holding 
a meeting to discuss the Commission's business for the month. This 
business meeting is open to the public. Computer assisted real-time 
transcription (CART) will be provided. The web link to access CART (in 
English) on Friday, June 24, 2022, is https://www.streamtext.net/player?event=USCCR. Please note that CART is text-only translation that 
occurs in real time during the meeting and is not an exact transcript.

Meeting Agenda

I. Approval of Agenda
II. Business Meeting
    A. Presentations by State Advisory Committee Chairs on Released 
Reports and Memorandums
    B. Discussion and Vote on Advisory Committee Appointments
    C. Discussion and Vote on 2022 Statutory Enforcement Report on FEMA
    D. Management and Operations
    <bullet> Staff Director's Report
III. Adjourn Meeting


[[Page 36455]]


    Dated: June 15, 2022.
Angelia Rorison,
USCCR Media and Communications Director.
[FR Doc. 2022-13201 Filed 6-15-22; 11:15 am]
BILLING CODE 6335-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>